• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996年至2007年加拿大安大略省慢性阻塞性肺疾病的患病率、发病率和死亡率趋势:一项基于人群的研究。

Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.

作者信息

Gershon Andrea S, Wang Chengning, Wilton Andrew S, Raut Roxana, To Teresa

机构信息

Institute for Clinical Evaluation Sciences, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

出版信息

Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17.

DOI:10.1001/archinternmed.2010.17
PMID:20308643
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with a prevalence of more than 10% worldwide among adults 40 years and older. Whether this amount has been increasing, decreasing, or stable over time remains unknown.

METHODS

A longitudinal cohort study using population-based, health administrative data from 1991 to 2007 was conducted in Ontario, Canada. Individuals with COPD were identified using a previously validated health administrative case definition of COPD. Annual COPD prevalence, incidence, and all-cause mortality rates were estimated from 1996 to 2007.

RESULTS

The prevalence of COPD increased by 64.8% between 1996 and 2007. The age- and sex-standardized COPD prevalence rate increased from 7.8% to 9.5%, representing a relative increase of 23.0% (P < .001). The age- and sex-standardized incidence decreased from 11.8 per 1000 adults to 8.5 per 1000 adults, representing a relative decrease of 28.3% (P < .001). Finally, the age- and sex-standardized all-cause mortality rate decreased from 5.7% to 4.3%, representing a relative decrease of 24.0% (P < .001).

CONCLUSIONS

Our findings indicate a substantial increase in COPD prevalence in the last decade, with more of the burden being shifted from men to women. Effective clinical and public health strategies are needed to prevent COPD and manage the increasing number of people living longer with this disease.

摘要

背景

慢性阻塞性肺疾病(COPD)是一种可预防和可治疗的疾病,在全球40岁及以上成年人中的患病率超过10%。随着时间的推移,这一患病率是上升、下降还是保持稳定尚不清楚。

方法

在加拿大安大略省进行了一项纵向队列研究,使用1991年至2007年基于人群的卫生行政数据。通过先前验证的COPD卫生行政病例定义来识别COPD患者。估计了1996年至2007年的年度COPD患病率、发病率和全因死亡率。

结果

1996年至2007年期间,COPD患病率增加了64.8%。年龄和性别标准化的COPD患病率从7.8%上升至9.5%,相对增加了23.0%(P <.001)。年龄和性别标准化发病率从每1000名成年人中的11.8例降至8.5例,相对下降了28.3%(P <.001)。最后,年龄和性别标准化的全因死亡率从5.7%降至4.3%,相对下降了24.0%(P <.001)。

结论

我们的研究结果表明,在过去十年中COPD患病率大幅上升,且更多的负担从男性转移到了女性。需要有效的临床和公共卫生策略来预防COPD,并管理越来越多患有这种疾病且寿命更长的人群。

相似文献

1
Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.1996年至2007年加拿大安大略省慢性阻塞性肺疾病的患病率、发病率和死亡率趋势:一项基于人群的研究。
Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17.
2
Trends in asthma prevalence and incidence in Ontario, Canada, 1996-2005: a population study.1996-2005 年加拿大安大略省哮喘患病率和发病率趋势:一项人群研究。
Am J Epidemiol. 2010 Sep 15;172(6):728-36. doi: 10.1093/aje/kwq189. Epub 2010 Aug 17.
3
[Epidemiology of chronic obstructive pulmonary disease in France].[法国慢性阻塞性肺疾病的流行病学]
Rev Mal Respir. 2010 Feb;27(2):160-8. doi: 10.1016/j.rmr.2009.08.003. Epub 2010 Jan 19.
4
Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中与社会经济地位相关的死亡率差异趋势。
Ann Am Thorac Soc. 2014 Oct;11(8):1195-202. doi: 10.1513/AnnalsATS.201403-094OC.
5
Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.亚太地区各国和各地区慢性阻塞性肺疾病(COPD)死亡率及住院率的趋势。
Respirology. 2009 Jan;14(1):90-7. doi: 10.1111/j.1440-1843.2008.01415.x.
6
Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012.加拿大安大略省 1996-2012 年 COPD 患者的男女死亡率趋势。
Thorax. 2015 Feb;70(2):121-6. doi: 10.1136/thoraxjnl-2014-205956. Epub 2014 Nov 26.
7
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.1971 - 2000年美国慢性阻塞性肺疾病监测
Respir Care. 2002 Oct;47(10):1184-99.
8
Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.在慢性阻塞性肺疾病中,噻托溴铵与长效β2受体激动剂相比的生存率。
COPD. 2008 Aug;5(4):229-34. doi: 10.1080/15412550802237507.
9
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].[德国慢性阻塞性肺疾病(COPD)的患病率。BOLD研究结果]
Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3.
10
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study.45至84岁丹麦人群中慢性阻塞性肺疾病的患病率:基于人群的研究。
COPD. 2008 Dec;5(6):347-52. doi: 10.1080/15412550802522635.

引用本文的文献

1
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease.噻托溴铵起始治疗与慢性阻塞性肺疾病患者的痴呆风险
JAMA Intern Med. 2025 May 19. doi: 10.1001/jamainternmed.2025.1251.
2
Geriatric nutritional risk index as a predictor of mortality in women with chronic inflammatory airway disease: evidence from NHANES 1999-2018.老年营养风险指数作为慢性炎症性气道疾病女性死亡率的预测指标:来自1999 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Nutr. 2025 Mar 10;12:1547952. doi: 10.3389/fnut.2025.1547952. eCollection 2025.
3
Patterns of recurrence among adults diagnosed with screen-detected lung cancer.
经筛查发现的肺癌成年患者的复发模式。
Cancer Epidemiol. 2025 Apr;95:102777. doi: 10.1016/j.canep.2025.102777. Epub 2025 Feb 18.
4
Trends in the prevalence and incidence of chronic obstructive pulmonary disease among adults aged ≥50 years in the United States, 2000-2020.2000 - 2020年美国50岁及以上成年人慢性阻塞性肺疾病的患病率和发病率趋势
Chronic Dis Transl Med. 2024 May 31;10(4):302-311. doi: 10.1002/cdt3.135. eCollection 2024 Dec.
5
Fine Particulate Matter Components and Risk of Rheumatoid Arthritis: A Large General Canadian Open Cohort Study.细颗粒物成分与类风湿关节炎风险:一项大型加拿大普通开放队列研究
Arthritis Care Res (Hoboken). 2025 Jan;77(1):15-22. doi: 10.1002/acr.25403. Epub 2024 Aug 9.
6
Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population Study.COVID-19 大流行对慢性阻塞性肺疾病医疗保健利用、加重和死亡率的影响:一项人群研究。
Ann Am Thorac Soc. 2024 Sep;21(9):1281-1288. doi: 10.1513/AnnalsATS.202312-1078OC.
7
[Not Available].[无可用内容]。
CMAJ. 2023 Nov 14;195(44):E1527-E1529. doi: 10.1503/cmaj.230998-f.
8
Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care.加拿大初级保健中慢性阻塞性肺疾病合并心力衰竭的流行病学和治疗。
ESC Heart Fail. 2023 Dec;10(6):3612-3621. doi: 10.1002/ehf2.14497. Epub 2023 Oct 3.
9
How can Canada's health systems improve care for people with chronic obstructive pulmonary disease?加拿大的医疗系统如何改善对慢性阻塞性肺疾病患者的护理?
CMAJ. 2023 Sep 11;195(35):E1182-E1183. doi: 10.1503/cmaj.230998.
10
Risk and distribution of chronic obstructive pulmonary disease-related hospitalizations among primary care patients.慢性阻塞性肺疾病相关住院患者的风险和分布情况。
Can Fam Physician. 2023 Jun;69(6):409-414. doi: 10.46747/cfp.6906409.